Policy decisions on endocrine disruptors should be based on science across disciplines: A response to Dietrich et al.

Endocrinology

Volumn 154, Issue 11, 2013, Pages 3957-3960

  Gore, Andrea C ^a   Balthazart, J ^b   Bikle, D ^c   Carpenter, D O ^d   Crews, D ^a   Czernichow, P ^e   Diamanti Kandarakis, E ^f   Dores, R M ^g   Grattan, D ^h   Hof, P R ⁱ   Hollenberg, A N ^j   Lange, C ^k   Lee, A V ^l   Levine, J E ^m   Millar, R P ⁿ   Nelson, R J ^o   Porta, M ^p   Poth, M ^q   Power, D M ^r   Prins, G S ^s   Ridgway, E C ^t   Rissman, E F ^u   Romijn, J A ^v   Sawchenko, P E ^w   Sly, P D ^x   Soder O ^y   Taylor, H S ^z   Tena Sempere, M ^aa   Vaudry, H ^ab   Wallen, K ^ac   Wang, Z ^ad   Wartofsky, L ^ae   Watson, C S ^af   more..

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e University of Paris II   (France)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^g UNIVERSITY OF DENVER   (United States)

^h UNIVERSITY OF OTAGO   (New Zealand)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

^m UNIVERSITY OF WISCONSIN   (United States)

ⁿ UNIVERSITY OF CAPE TOWN   (South Africa)

^o THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^p UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^q UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^r UNIVERSITY OF ALGARVE   (Portugal)

^s UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^t UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^u UNIVERSITY OF VIRGINIA   (United States)

^v UNIVERSITY OF AMSTERDAM   (Netherlands)

^w SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^x UNIVERSITY OF QUEENSLAND   (Australia)

^y KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^z YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa UNIVERSITY OF CÓRDOBA   (Spain)

^ab UNIVERSITÉ DE ROUEN   (France)

^ac EMORY UNIVERSITY   (United States)

^ad FLORIDA STATE UNIVERSITY   (United States)

^ae WASHINGTON HOSPITAL CENTER   (United States)

^af University of Texas Medical Branch School of Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR;

ENDOCRINE SYSTEM; EUROPE; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

ADVISORY COMMITTEES; ANIMALS; ENDOCRINE DISRUPTORS; HUMANS;

EID: 84886442571     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1854     Document Type: Review

References (22)

1. American Society of Human Genetics, American Society for Reproductive Medicine, Endocrine Society, Genetics Society of America, Society for Developmental Biology, Society for Pediatric Urology, Society for the Study of Reproduction, Society for Gynecologic Investigation. Assessing chemical risk: societies offer expertise. Science. 2011;331:1136.
2. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine- disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30: 293-342.
3. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine- disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33: 378-455.
4. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology. 2012;153: 4097-4110.
5. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT, eds. State of the Science of Endocrine Disrupting Chemicals-2012. An Assessment of the State of the Science of Endocrine Disruptors Prepared by a Group of Experts for the United Nations Environment Programme and World Health Organization. Geneva, Switzerland: United Nations Environment Programme and the World Health Organization; 2013.
6. Dietrich DR, Aulock SV, Marquardt H, et al. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. Chem Biol Interact. 2013;205:A1-A5.
7. Vandenberg LN, Colborn T, Hayes TB, et al. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol. 2013;38: 1-15.
8. Birnbaum LS. Environmental chemicals: evaluating low-dose effects. Environ Health Perspect. 2012;120:A143-A144.
9. Phoenix CH, Goy RW, Gerall AA, Young WC. Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology. 1959;65: 369-382.
10. Wallen K. The Organizational Hypothesis: reflections on the 50th anniversary of the publication of Phoenix, Goy, Gerall, and Young (1959). Horm Behav. 2009;55: 561-565.
11. Boobis AR, Daston GP, Preston RJ, Olin SS. Application of key events analysis to chemical carcinogens and noncarcinogens. Crit Rev Food Sci Nutr. 2009;49: 690-707.
12. Borgert CJ, Sargent EV, Casella G, Dietrich DR, McCarty LS, Golden RJ. The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. Regul Toxicol Pharmacol. 2012;62: 313-328.
13. Piersma AH, Hernandez LG, van Benthem J, et al. Reproductive toxicants have a threshold of adversity. Crit Rev Toxicol. 2011;41: 545-554.
14. Rhomberg LR, Goodman JE, Haber LT, et al. Linear low-dose extrapolation for noncancer health effects is the exception, not the rule. Crit Rev Toxicol. 2011;41: 1-19.
15. Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: Has the case been made? Regul Toxicol Pharmacol. 2012;64: 130-133.
16. vom Saal FS, Sheehan DM. Challenging risk assessment. Forum Appl Res Public Policy. 1998;13: 11-18.
17. Sheehan DM, Willingham E, Gaylor D, Bergeron JM, Crews D. No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much? Environ Health Perspect. 1999;107: 155-159.
18. Sheehan DM, vom Saal FS. Low dose effects of hormones: a challenge for risk assessment. Risk Policy Rep. 1997;4: 31-39.
19. Sheehan DM. No-threshold dose-response curves for nongenotoxic chemicals: findings and applications for risk assessment. Environ Res. 2006;100: 93-99.
20. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. Large effects from small exposures. I. Mechanisms for endocrine- disrupting chemicals with estrogenic activity. Environ Health Perspect. 2003;111: 994-1006.
21. Grandjean P, Ozonoff D. Transparency and translation of science in a modern world. Environ Health. 2013;12:70.
22. Bergman A, Andersson AM, Becher G, et al. Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors. Environ Health. 2013;12:69.